Section Editors

Section Board for 'Cancer Therapeutics' (9)

Please see the section webpage for more information on this section.

Dr. Veronique Baud
Section Editor-in-Chief
1. NF-kB, Differentiation and Cancer, University Paris Descartes, Sorbonne Paris Cité, 75014 Paris, France
2. Faculté de Pharmacie, 4 Avenue de l'Observatoire, 75006 Paris, France
Interests: Interface between signal transduction and cancer with a focus on the alternative NF-κB signaling pathway, how it is regulated, and its contributions toward tumor development and resistance to conventional cancer therapies
Special Issues and Collections in MDPI journals:
Dr. Mike-Andrew Westhoff
Ulm University | UULM Clinic of Pediatric and Adolescent Medicine
Interests: glioblastoma; combination therapy; apoptosis; temozolomide
Special Issues and Collections in MDPI journals:
Prof. Dr. Michael J Gonzalez
Department of Human Development Nutrition Program, School of Public Health, University of Puerto Rico Medical Sciences Campus, GPO Box 365067 San Juan PR 00936-5067,USA
Interests: lipid peroxidation;Orthomolecular medicine; Cancer and non toxic therapies; metabolic correction
Dr. Eliana Bignotti
Division of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, Italy
Interests: gynecological cancers; diagnosis; prognosis; miRNA; gene expression
Prof. Antonio Biondi
Department of General Surgery and Surgical - Medical Specialties, University of Catania, Italy
Interests: cancer; colorectal cancer; surgery; laparoscopic surgery; nutrition; quality of life
Dr. Muhammad Hanif
The University of Auckland, School of Chemical Sciences, 23 Symonds Street, Room 302.1033, Auckland 1010, New Zealand
Interests: synthetic inorganic chemistry; bioinorganic chemistry and chemical biology; utilising an interdisciplinary approach for the design and development of metal complexes for biomedical applicationsand its contributions toward tumor development and resistance to conventional cancer therapies
Dr. Paola Maroni
IRCCS, Istituto Ortopedico Galeazzi, Milan, Italy
Interests: Breast cancer; bone metastasis; tumour microenvironment; signal transduction; HGF; Met; Epithelial-Mesenchymal transition (EMT); mesenchymal-epithelial transition (MET); protein kinases; invasive growth; animal models; immunohistochemistry
Special Issues and Collections in MDPI journals:
Prof. Dr. Catherine Thieblemont
1. Haematology in the University of Paris, Paris, France
2. The Hemato-Oncology Department in the Hospital Saint-Louis, Paris, France
Interests: the biological and clinical features of lymphomas; targeted therapies; immunotherapies and CAR T cells; genomic and metabolomic studies on low and high grade lymphomas
Dr. Jacqueline Lehmann-Che
Molecular Oncology Unit, Department of solid tumor genomics and INSERM U976, University of Paris, France
Interests: Molecular oncology; molecular biology; genetics; biochemistry; breast cancer; solid tumors
Back to TopTop